AYTU BIOPHARMA, INC
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -42.4% | -42.4% | -21.9% |
| FY2022 | -245.5% | -183.4% | -79.0% |
| FY2023 | -43.3% | -31.5% | -12.5% |
| FY2024 | -57.2% | -41.1% | -13.4% |
| FY2025 | -71.5% | -45.4% | -10.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -42.4% | -42.4% | -21.9% |
| FY2022 | -245.5% | -183.4% | -79.0% |
| FY2023 | -43.3% | -31.5% | -12.5% |
| FY2024 | -57.2% | -41.1% | -13.4% |
| FY2025 | -71.5% | -45.4% | -10.9% |